You are here

serelaxin

Novartis’ Heart Drug Fails Late Stage Trials

Investopedia

Wed, 03/22/17 - 11:13 am

acute heart failure

Novartis Fails to Win U.S. Approval for Serelaxin Heart Drug

Bloomberg

Fri, 05/16/14 - 07:54 am

Just a Standard “Breakthrough”: FDA’s Unusual Designations for Novartis’ Serelaxin

Pharma and MedTech Business Intelligence

Tue, 04/1/14 - 08:12 am

FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug

Forbes

Thu, 03/27/14 - 04:58 pm

acute heart failure

advisory panels

FDA staff review recommends against Novartis heart failure drug

Yahoo/Reuters

Tue, 03/25/14 - 08:36 am

acute heart failure

advisory panels

Novartis: Running Fast to Stand Still?

Motley Fool

Mon, 01/27/14 - 09:11 am

acute heart failure

FDA Advisory Panel To Review New Heart Failure Drug From Novartis

Forbes

Tue, 01/7/14 - 12:26 pm

advisory panels

Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline

Fierce Biotech

Thu, 10/17/13 - 06:18 pm

Cleveland Clinic

These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation

Motley Fool

Tue, 09/3/13 - 09:33 am

breakthrough therapies

Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA

Forbes

Thu, 06/27/13 - 08:52 pm

breakthrough therapies

This Week in Biotech

Motley Fool

Sun, 06/23/13 - 11:11 am

pain management

prostage cancer

3 Potential Game Changers for America's No. 1 Killer

Motley Fool

Wed, 04/17/13 - 04:36 pm

PCSK9 inhibitors

Novartis says expects to have 14 new blockbusters by 2017

Reuters

Thu, 11/8/12 - 10:57 am

AHA - 2 Hits And Several Misses With Novartis' Serelaxin

Seeking Alpha

Wed, 11/7/12 - 12:36 pm

shortness of breath

Novartis: RLX030 reduced deaths in patients with acute heart failure

Yahoo/Fly on the Wall

Mon, 09/24/12 - 10:21 am